focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,775.00
Bid: 1,774.50
Ask: 1,775.50
Change: 0.00 (0.00%)
Spread: 1.00 (0.056%)
Open: 1,775.50
High: 1,778.50
Low: 1,769.00
Prev. Close: 1,775.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Investec And Jefferies Keep Buy On Lloyds

Thu, 28th Apr 2016 08:28

LONDON (Alliance News) - The following shares received analyst recommendations Thursday morning and Wednesday:
----------
FTSE 100
----------
Investec Reiterates Buy And 78p Price Target On Lloyds
----------
Jefferies Maintains Buy And "Street High" 108p Price Target On Lloyds
----------
Deutsche Bank Ups Barclays Target To 180p From 178p, Keeps Hold
----------
HSBC RAISES STANDARD CHARTERED PRICE TARGET TO 550 (450) PENCE - 'HOLD'
----------
EXANE BNP RAISES STANDARD CHARTERED TARGET TO 450 (385) PENCE - 'UNDERPERFORM'
----------
Deutsche Bank Ups Antofagasta Target To 470p From 450p, Keeps Hold
----------
BERENBERG CUTS ANTOFAGASTA PRICE TARGET TO 365 (375) PENCE - 'SELL'
----------
HSBC RAISES GLAXOSMITHKLINE PRICE TARGET TO 1865 (1800) PENCE - 'BUY'
----------
SOCGEN RAISES GLAXOSMITHKLINE PRICE TARGET TO 1300 (1250) PENCE - 'SELL'
----------
Jefferies Initiates United Utilities Group With Hold, Target At 890p
----------
GOLDMAN CUTS MARKS & SPENCER PRICE TARGET TO 380 (455) PENCE - 'SELL'
----------
GOLDMAN RAISES INTU PROPERTIES TO 'NEUTRAL' ('SELL') - TARGET 350 (335) PENCE
----------
GOLDMAN CUTS NEXT TO 'SELL' ('NEUTRAL') - TARGET 5000 (6400) PENCE
----------
RBC CAPITAL RAISES BAT PRICE TARGET TO 3400 (3300) PENCE - 'UNDERPERFORM'
----------
MORGAN STANLEY RAISES BAT PRICE TARGET TO 4300 (4100) PENCE - 'EQUAL-WEIGHT'
----------
RBC CAPITAL RAISES RECKITT PRICE TARGET TO 7100 (6600) PENCE - 'SECTOR PERFORM'
----------
RBC CAPITAL RAISES UNILEVER PLC PRICE TARGET TO 3300 (3200) PENCE - 'OUTPERFORM'
----------
MORGAN STANLEY INITIATES BUNZL WITH 'EQUAL-WEIGHT' - TARGET 2200 PENCE
----------
FTSE 250
----------
DEUTSCHE BANK CUTS STAGECOACH PRICE TARGET TO 365 (390) PENCE - 'BUY'
----------
RBC CUTS STAGECOACH TARGET TO 280 (315) PENCE - 'SECTOR PERFORM'
----------
DEUTSCHE BANK RAISES COBHAM TO 'HOLD' ('SELL') - CUTS TARGET TO 185 PENCE
----------
JPMORGAN RAISES EVRAZ PRICE TARGET TO 98 (79) PENCE - 'UNDERWEIGHT'
----------
BARCLAYS RAISES CAIRN ENERGY PRICE TARGET TO 230 (220) PENCE - 'EQUAL WEIGHT'
----------
SOCGEN RAISES HENDERSON GROUP PRICE TARGET TO 260 (235) PENCE - 'HOLD'
----------
CITIGROUP RAISES HENDERSON GROUP PRICE TARGET TO 289 PENCE - 'BUY'
----------
MAIN MARKET AND AIM
----------
JPMORGAN RAISES FENNER PRICE TARGET TO 111 (110) PENCE - 'UNDERWEIGHT'
----------
JPMORGAN RAISES CAMBIAN GROUP PRICE TARGET TO 119 (109) PENCE - 'NEUTRAL'
----------
BARCLAYS RAISES PREMIER OIL PRICE TARGET TO 75 (50) PENCE - 'EQUAL WEIGHT'
----------
Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more
9 Jan 2024 08:03

TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion

(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments.

Read more
9 Jan 2024 07:16

GSK buys respiratory drug maker Aiolos for $1bn

(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).

Read more
8 Jan 2024 23:39

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 23:00

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.